FIVE PRIME THERAPEUTICS INC Contracts & Agreements

123 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Five Prime Therapeutics Golden Parachute Gross-Up Payment Agreement with Employee (April 2021)
Change of Control Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2021
Agreement and Plan of Merger among Amgen Inc., Franklin Acquisition Sub, Inc., and Five Prime Therapeutics, Inc. dated March 4, 2021
Merger Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2021
Employment Agreement between Five Prime Therapeutics, Inc. and Thomas Civik as President and CEO
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment to Employment Offer Letter between Five Prime Therapeutics, Inc. and William R. Ringo (April 2020)
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Sales Agreement between Five Prime Therapeutics, Inc. and Cowen and Company, LLC for Up to $75,000,000 of Common Stock
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2020
Waiver of Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and William R. Ringo
Waiver Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – FPRX
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment to Employment Offer Letter between Five Prime Therapeutics, Inc. and William R. Ringo (December 20, 2019)
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement Regarding Executive Severance Benefits – Five Prime Therapeutics, Inc. and Francis Sarena
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement Modifying Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and David Smith
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Five Prime Therapeutics, Inc. Retention Bonus Agreement with David Smith (January 2020)
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Five Prime Therapeutics, Inc. Retention Bonus Agreement with Helen Collins, M.D. (January 2020)
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Five Prime Therapeutics, Inc. Retention Bonus Agreement with Francis Sarena (January 2020)
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Letter Agreement Modifying Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Helen Collins, M.D.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Five Prime Therapeutics, Inc. Executive Severance Benefit Plan and Summary Plan Description (Effective November 20, 2019)
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2020
Five Prime Therapeutics Non-Employee Director Compensation Policy (Effective November 21, 2019)
Compensation Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment No. 3 to Non-Exclusive License Agreement among Lonza Sales AG, BioWa, Inc., and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 4 to Non-Exclusive License Agreement among Five Prime Therapeutics, BioWa, and Lonza
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Separation Agreement between Five Prime Therapeutics, Inc. and Aron M. Knickerbocker (September 19, 2019)
Separation Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Interim Chief Executive Officer Employment Offer Letter between Five Prime Therapeutics, Inc. and William R. Ringo
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment to Employment Offer Letter between Five Prime Therapeutics, Inc. and William R. Ringo
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Consulting Agreement between Five Prime Therapeutics, Inc. and Lewis T. Williams, Effective April 1, 2019
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Employment Offer Letter between Five Prime Therapeutics, Inc. and Bryan Irving, Ph.D.
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Five Prime Therapeutics, Inc. Executive Employment Offer Letter to David V. Smith (CFO)
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Bryan Irving, Ph.D.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and David Smith
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2019
Amendment No. 1 to Confidential Consulting Agreement between Five Prime Therapeutics, Inc. and FLG Partners, LLC
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 1 to Non-Exclusive License Agreement between Lonza Sales AG, BioWa, Inc., and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 2 to Non-Exclusive License Agreement among BioWa, Inc., Lonza Sales AG, and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 1 to License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Zai Lab (Shanghai) Co., Ltd.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Consulting Agreement between Five Prime Therapeutics, Inc. and Marc Belsky, Effective April 7, 2018
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Confidential Consulting Agreement between FLG Partners, LLC and Five Prime Therapeutics, Inc.
Consulting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Employment Offer Letter for Executive Chairman between Five Prime Therapeutics, Inc. and Lewis T. Williams
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Employment Offer Letter between Five Prime Therapeutics, Inc. and Helen Collins, M.D.
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Executive Severance Benefits Agreement between Helen Collins and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2018
Five Prime Therapeutics, Inc. Annual Bonus Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Amendment No. 2 to Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Zai Lab (Shanghai) Co., Ltd.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2018
Underwriting Agreement between Five Prime Therapeutics, Inc. and Underwriters (Goldman Sachs, J.P. Morgan, Leerink Partners) for Common Stock Offering
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2018
Five Prime Therapeutics, Inc. Annual Bonus Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Employment Agreement between Five Prime Therapeutics, Inc. and Aron Knickerbocker as President and CEO
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Amendment No. 2 to Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Aron Knickerbocker
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Amendment No. 1 to the 2013 Omnibus Incentive Plan by Five Prime Therapeutics, Inc.
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Confidential Resignation Agreement and General Release of Claims between Five Prime Therapeutics, Inc. and Robert Sikorski, M.D., Ph.D.
Separation Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Employment Offer Letter between Five Prime Therapeutics, Inc. and Robert Sikorski, M.D., Ph.D.
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Five Prime Therapeutics, Inc. Employment Offer Letter to Kevin Paul Baker, Ph.D.
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Robert Sikorski
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Amendment No. 1 to Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Robert Sikorski
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2017
Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Kevin Paul Baker, Ph.D.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement with Award Recipient
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2017
Amendment to Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (May 16, 2016)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2016
Executive Transition and Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Julie Hambleton, M.D.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2016
Amendment No. 2 to Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2016
Amendment No. 3 to Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2016
Amendment No. 1 to Research Collaboration and License Agreement between Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2016
Research Collaboration and License Agreement between Five Prime Therapeutics, Inc. and INBRX 110 LP
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2015
Five Prime Therapeutics, Inc. Retention Award Agreement with Employee (April 30, 2015)
Retention Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2015
Clinical Trial Collaboration Agreement between Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2015
Amendment No. 2 to Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2014
Amendment No. 1 to Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Research Collaboration and License Agreement between Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Five Prime Therapeutics, Inc. Employment Offer Letter to Julie Hambleton, M.D.
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
Employment Offer Letter between Five Prime Therapeutics, Inc. and Marc L. Belsky (Vice President, Finance)
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
Amendment No. 1 to Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Marc Belsky
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
Non-Exclusive License Agreement between National Research Council of Canada and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Non-Exclusive License Agreement between Stanford University and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Amendment No. 1 to License Agreement between Stanford University and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Technology License Agreement between National Research Council of Canada and Five Prime Therapeutics Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amending Agreement to Technology License between National Research Council of Canada and Five Prime Therapeutics Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Indemnification Agreement between Five Prime Therapeutics, Inc. and Officer or Director
Indemnification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Research Collaboration and License Agreement between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Amendment No. 1 to Research Collaboration and License Agreement between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (December 22, 2011)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Exclusive License Agreement between The Regents of the University of California and Five Prime Therapeutics, Inc. for Fibroblast Growth Factor Receptors
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Non-Exclusive License Agreement between BioWa, Inc., Lonza Sales AG, and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
IA
2013
Five Prime Therapeutics, Inc. 2002 Equity Incentive Plan (as Amended and Restated)
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Five Prime Therapeutics Employment Offer Letter to Aron M. Knickerbocker (Vice President, Business Development)
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. Employment Offer Letter to Francis Sarena as Vice President, General Counsel and Corporate Secretary
Employment Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Indemnity Agreement between Five Prime Therapeutics, Inc. and Indemnitee
Indemnification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Research Collaboration and License Agreement between UCB Pharma S.A. and Five Prime Therapeutics, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
License and Collaboration Agreement between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Research Collaboration and License Agreement between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Amendment No. 1 to Research Collaboration and License Agreement between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Exclusive License Agreement between Five Prime Therapeutics, Inc. and Galaxy Biotech, LLC (December 22, 2011)
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Exclusive License Agreement between The Regents of the University of California and Five Prime Therapeutics, Inc. for Fibroblast Growth Factor Receptors
License Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Master Services Agreement between Five Prime Therapeutics, Inc. and Cytovance Biologics Inc. dated October 1, 2012
Services Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Underwriting Agreement between Five Prime Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC (November 12, 2020)
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2020
Sublease Agreement between Five Prime Therapeutics, Inc. and Sutro Biopharma, Inc. dated September 3, 2020
Lease Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2020
Amendment to Stock Option Agreements between Five Prime Therapeutics, Inc. and Marc Belsky
Modification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Lease Agreement between HCP Oyster Point III LLC and Five Prime Therapeutics, Inc. for The Cove at Oyster Point
Lease Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2017
Underwriting Agreement for 3,410,000 Shares of Common Stock of Five Prime Therapeutics, Inc. with Citigroup, Leerink, and Wells Fargo
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2015
First Amendment to Lease Agreement between Britannia Biotech Gateway Limited Partnership and Five Prime Therapeutics, Inc.
Lease Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2014
Stock Purchase Agreement between Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc. dated March 14, 2014
Purchase Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Underwriting Agreement between Five Prime Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp., and Wells Fargo Securities, LLC
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Restricted Stock Agreement
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2014
Executive Severance Benefits Agreement between Julie Hambleton, MD and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2014
Executive Severance Benefits Agreement between Marc L. Belsky and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2014
Underwriting Agreement between Five Prime Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp., and Wells Fargo Securities, LLC (2013)
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Common Stock Certificate for Five Prime Therapeutics, Inc.
Stock Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. Series A Preferred Stock Warrant Agreement
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Warrant Agreement to Purchase Series A Preferred Stock between Five Prime Therapeutics, Inc. and General Electric Capital Corporation (January 26, 2004)
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Seventh Amended and Restated Investor Rights Agreement among Five Prime Therapeutics, Inc. and Investors (April 16, 2012)
Investor Rights Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Five Prime Therapeutics, Inc. 2002 Equity Incentive Plan Stock Option Agreement
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan Option Agreement
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Incentive Stock Option Agreement
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. 2013 Omnibus Incentive Plan Non-Qualified Stock Option Agreement
Bonus & Incentive Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Executive Severance Benefits Agreement between Lewis T. Williams and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Executive Severance Benefits Agreement between Aron M. Knickerbocker and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Amendment No. 1 to Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Aron Knickerbocker
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Executive Severance Benefits Agreement between Francis Sarena and Five Prime Therapeutics, Inc.
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Amendment No. 1 to Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and Francis Sarena
Severance Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment No. 1 to Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Modification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Lease Agreement between Britannia Biotech Gateway Limited Partnership and Five Prime Therapeutics, Inc. dated March 22, 2010
Lease Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Sublease Agreement between Amgen SF, LLC and Five Prime Therapeutics, Inc. dated March 22, 2010
Lease Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. Stock Option Grant Notice to Aron Knickerbocker (2002 Equity Incentive Plan)
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment to Stock Option Agreement between Five Prime Therapeutics, Inc. and Aron Knickerbocker (March 15, 2011)
Stock Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013